[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335888-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335888-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","impact-of-the-sars-cov-2-outbreak-on-the-initial-clinical-presentation-of-new-solid-cancer-diagnoses-a-systematic-review-and-meta-analysis","Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses - a systematic review and meta-analysis","","The COVID-19 pandemic may have delayed cancer diagnosis and management, prompting a systematic review to compare the initial tumor stage of newly diagnosed solid cancers before versus after the initial pandemic waves. Articles were reviewed for studies reporting metastatic rates and stage distributions, followed by a random-effects meta-analysis. Subgroup analyses assessed primary tumor site and country differences. Findings based on 58 studies and 109,996 patients showed a higher proportion of metastatic tumors after the outbreak and statistically significant effects for selected cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-the-sars-cov-2-outbreak-on-the-initial-clinical-presentation-of-new-solid-cancer-diagnoses-a-systematic-review-and-meta-analysis/335888/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-the-sars-cov-2-outbreak-on-the-initial-clinical-presentation-of-new-solid-cancer-diagnoses-a-systematic-review-and-meta-analysis/335888.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of the systematic review?","Question",{"text":63,"@type":64},"To compare the proportion of metastatic presentations and the distribution of initial tumor stage at diagnosis for patients with solid cancers before and after the COVID-19 outbreak.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study measure changes in cancer presentation?",{"text":68,"@type":64},"It reviewed articles comparing tumor stage of new solid cancer diagnoses before versus after the initial pandemic waves and conducted a random-effects meta-analysis to compare metastatic rates and stage distributions.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about metastatic tumors after the outbreak?",{"text":72,"@type":64},"The meta-analysis found a higher rate of metastatic tumors at diagnosis after the pandemic compared with before, with statistically relevant findings for some specific cancer types.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335888,1790153876,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Marty et al. BMC Cancer (2024) 24:143 [https://doi.org/10.1186/s12885-023-11795-1](https://doi.org/10.1186/s12885-023-11795-1)  \nBMC Cancer  \n RESEARCH Open Access  \nImpact of the Sars-Cov-2 outbreak    \non the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis  \nSimon Marty1, Guillaume Lamé2, Etienne Guével3, Sonia Priou2, Gilles Chatellier4, Christophe Tournigand1, Emmanuelle Kempf1,5* and a CRAB* initiative  \nAbstract  \nBackground The COVID-19 pandemic might have delayed cancer diagnosis and management. The aim ofthis systematic review was to compare the initial tumor stage of new cancer diagnoses before and after the pandemic. Methods We systematically reviewed articles that compared the tumor stage of new solid cancer diagnoses before and after the initial pandemic waves. We conducted a random-effects meta-analysis to compare the rate of metastatic tumors and the distribution of stages at diagnosis. Subgroup analyses were performed by primary tumor site and by country.  \nResults From 2,013 studies published between January 2020 and April 2022, we included 58 studies with 109,996 patients. The rate of metastatic tumors was higher after the COVID-19 outbreak than before (pooled OR: 1.29 (95% CI, 1.06-1. 57), I2: 89%(95% CI, 86-91)) . For specific cancers, common ORs reached statistical significance for breast (OR:  \n1.51 (95% CI 1.07-2. 12)) and gynecologic (OR: 1.51 (95% CI 1.04-2. 18)) cancers, but not for other cancer types. According to countries, common OR (95% CI) reached statistical significance only for Italy: 1.55 (1 .01-2. 39) and Spain:1 .14 (1 .02-1. 29) . Rates were comparable for stage I-II versus III-IV in studies for which that information was available, and for stages I-II versus stage III in studies that did not include metastatic patients.  \nConclusions Despite inter-study heterogeneity, our meta-analysis showed a higher rate of metastatic tumors at diagnosis after the pandemic. The burden of social distancing policies might explain those results, as patients may have delayed seeking care.  \nKeywords COVID-19, Delivery of health care, Early detection of cancer, Health services research, Neoplasm staging, Neoplasm metastasis  \n*Correspondence: Emmanuelle Kempf [Emmanuelle.kempf@aphp.fr](Emmanuelle.kempf@aphp.fr)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)[mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nMarty et al. BMC Cancer (2024) 24:143  \nBackground  \nIn 2020, the COVID-19 pandemic disrupted healthcare systems worldwide. In cancer care, screening programs were suspended in many countries, and care strategies were sometimes adapted to avoid exposing p","cbCaioXxoY88svNr","https://ap.wps.com/l/cbCaioXxoY88svNr","pdf",5595900,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Impact of the pandemic on healthcare and screening\n## Rationale for comparing tumor stage\n# Aim\n# Materials and methods\n## Reporting guidelines\n## Data sources and eligibility criteria","[{\"question\":\"What was the main objective of the systematic review?\",\"answer\":\"To compare the proportion of metastatic presentations and the distribution of initial tumor stage at diagnosis for patients with solid cancers before and after the COVID-19 outbreak.\"},{\"question\":\"How did the study measure changes in cancer presentation?\",\"answer\":\"It reviewed articles comparing tumor stage of new solid cancer diagnoses before versus after the initial pandemic waves and conducted a random-effects meta-analysis to compare metastatic rates and stage distributions.\"},{\"question\":\"What did the results show about metastatic tumors after the outbreak?\",\"answer\":\"The meta-analysis found a higher rate of metastatic tumors at diagnosis after the pandemic compared with before, with statistically relevant findings for some specific cancer types.\"}]","Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses - a systematic review and meta-analysis | PDF",1790012734,33]